Displaying 25 - 34 of 34
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Metabolism, Alcohol & Toxicity
5

Medscape: Making Headway in Hepatorenal Syndrome Management - ILC 2022

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Displaying 25 - 34 of 34